Exendin-4 decreases amphetamine-induced locomotor activity

K Erreger, AR Davis, AM Poe, NH Greig… - Physiology & …, 2012 - Elsevier
K Erreger, AR Davis, AM Poe, NH Greig, GD Stanwood, A Galli
Physiology & behavior, 2012Elsevier
Glucagon-like peptide-1 (GLP-1) is released in response to nutrient ingestion and is a
regulator of energy metabolism and consummatory behaviors through both peripheral and
central mechanisms. The GLP-1 receptor (GLP-1R) is widely distributed in the central
nervous system, however little is known about how GLP-1Rs regulate ambulatory behavior.
The abused psychostimulant amphetamine (AMPH) promotes behavioral locomotor activity
primarily by inducing the release of the neurotransmitter dopamine. Here, we identify the …
Glucagon-like peptide-1 (GLP-1) is released in response to nutrient ingestion and is a regulator of energy metabolism and consummatory behaviors through both peripheral and central mechanisms. The GLP-1 receptor (GLP-1R) is widely distributed in the central nervous system, however little is known about how GLP-1Rs regulate ambulatory behavior. The abused psychostimulant amphetamine (AMPH) promotes behavioral locomotor activity primarily by inducing the release of the neurotransmitter dopamine. Here, we identify the GLP-1R agonist exendin-4 (Ex-4) as a modulator of behavioral activation by AMPH. We report that in rats a single acute administration of Ex-4 decreases both basal locomotor activity as well as AMPH-induced locomotor activity. Ex-4 did not induce behavioral responses reflecting anxiety or aversion. Our findings implicate GLP-1R signaling as a novel modulator of psychostimulant-induced behavior and therefore a potential therapeutic target for psychostimulant abuse.
Elsevier